NCT06202898 Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
| NCT ID | NCT06202898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Transgender Women |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2023-07-11 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2023-07-11 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
Eligibility Criteria
Inclusion Criteria: * Aged ≥18 years * Male at birth * Identify as a woman/transgender woman * Should not be consistently using PrEP (less than four doses per week) * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program * Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write) * Have a smart phone that can take pictures Exclusion Criteria: * Unwilling to adhere to study procedures * Participation in an HIV vaccine trial * Have a life-threatening SUD\* * Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP * Unable to provide consent
Contact & Investigator
Elena Cyrus, PhD
PRINCIPAL INVESTIGATOR
University of Central Florida
Frequently Asked Questions
Who can join the NCT06202898 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Transgender Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06202898 currently recruiting?
Yes, NCT06202898 is actively recruiting participants. Contact the research team at elena.cyrus@ucf.edu for enrollment information.
Where is the NCT06202898 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06202898 clinical trial?
NCT06202898 is sponsored by University of Central Florida. The principal investigator is Elena Cyrus, PhD at University of Central Florida. The trial plans to enroll 110 participants.